Narrowing of spaces in the spine, which can cause pressure on the spinal cord and nerves, resulting in chronic pain.
Pain radiating along the sciatic nerve, usually from the lower back down through the legs. It may be covered under broader back and leg pain categories but is not specifically FDA-approved.
Chronic pain after spinal decompression surgery (laminectomy), often considered part of FBSS.
Pain from nerve root compression or inflammation, often resulting in back or leg pain. SCS can be used, though FDA approval is focused on broader categories of back and leg pain.
SCS for Post-Herpetic Neuralgia
Chronic pain following a shingles outbreak, which affects nerve fibers and skin.
SCS for Peripheral Vascular Disease (PVD)
Chronic pain related to poor circulation in the limbs, particularly the legs.
SCS for Painful Diabetic Neuropathy
Chronic pain due to nerve damage from diabetes, affecting extremities (hands, feet).
Damage to peripheral nerves causing numbness, tingling, and pain, often in the hands and feet. FDA approval depends on the specific condition.
SCS for Neuropathic Pain from MS
Chronic nerve pain caused by nerve damage from MS, though not specifically FDA-approved.
SCS for Failed Back Surgery Syndrome
Persistent or recurring pain following one or more spine surgeries.
SCS for Degenerative Disc Disease
Chronic pain caused by wear and tear of the discs in the spine, typically leading to lower back pain.
A chronic pain condition affecting a limb after injury or surgery, with disproportionate pain to the injury.
Inflammation of the arachnoid membrane around the spinal cord, often leading to chronic pain and nerve damage.
SCS can be used to manage chronic pain associated with cancer, but it is not specifically FDA-approved for this use.
SCS is used for chronic angina not relieved by medication or surgery, not FDA-approved in the U.S.